Genetic ablation of Mybpc3 causes myocardial disarray, impaired in vivo cardiac function, and reduces myofilament Ca2+ sensitivity, leading to cardiac fibrosis and hypertrophy in mouse models [6,7]. The gene discussed is MYBPC3; the disease is cardiac hypertrophy.